Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 29, 2018 - Issue sup3: Omalizumab treatment in patients with severe chronic spontaneus urticaria: considerations from real-life experiences
Submit an article Journal homepage
355
Views
4
CrossRef citations to date
0
Altmetric
Omalizumab treatment in patients with severe chronic spontaneous urticaria: consideration on efficacy from real-life experiences

Omalizumab therapy in a patient with cronic spontaneous urticaria, ulcerative colitis, hypereosinophilia and prurigo Besnier: a case report

T. GriecoDermatologic Clinic Sapienza University of Rome, Rome, Italy; Correspondence[email protected]
View further author information
,
C. ChelloDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information
,
V. FainaDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information
,
V. V. GomesUOC Anatomical Pathology, Belcolle Hospital, Viterbo, Italy; View further author information
,
L. AleiDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information
,
A. SernicolaDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information
,
V. PanasitiCampus Bio Medico, Dermatologic Clinic, Rome, ItalyView further author information
&
S. CalvieriDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information
 show all
Pages 10-13 | Received 20 Feb 2018, Accepted 19 Sep 2018, Published online: 03 Jan 2019

References

  • Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73:1393–1414.
  • Tu¨rk M, Yılmaz I, Bahçecioglu SN. Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients. Allergol Int. 2017;67:85–89.
  • Zuberbier T, Maurer M. Omalizumab for the treatment of chronic urticaria. Expert Rev Clin Immunol. 2015;11:171–180.
  • Kaplan AP, Giménez-Arnau AM, Saini SS. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Allergy. 2017;72:519–533.
  • Saini S, Bindslev-Jensen C, Maurer M, et al. Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study. J Invest Dermatol. 2014;135:67–75.
  • Kim YS, Han K, Lee JH, et al. Increased risk of chronic spontaneous urticaria in patients with autoimmune thyroid diseases: a nationwide, population-based study. Allergy Asthma Immunol Res. 2017;9:373–377.
  • Chang TW, Chen C, Lin CJ, et al. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria. J Allergy Clin Immunol. 2015;135:337–342.
  • Tsianakas A, Zeidler C, Stander S. Prurigo nodularis management. Curr Probl Dermatol. 2016;50:94–101.
  • Rishi R, Ringwala S, Tracy J, et al. Prurigo nodularis and Hashimoto thyroiditis. Ann Allergy Asthma Immunol. 2014;113:673–674.
  • Fukushi S, Yamasaki K, Aiba S. Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis. Br J Dermatol. 2011;165:990–996.
  • Zeidler C, Ständer S. The pathogenesis of Prurigo nodularis-'Super-Itch' in exploration. Eur J Pain. 2016;20:37–40.
  • Fernández-Antón Martínez MC, Leis-Dosil V, Alfageme-Roldán F, et al. Omalizumab for the treatment of atopic dermatitis. Actas Dermosifiliogr. 2012;103:624–628.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.